Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03075163 · ClinicalTrials.gov registry record · Phase 4
Post-Operative Therapy for Nausea or Vomiting
A Phase 4 study, sponsored by University of California, Davis.
- Terminated
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT03075163 is a Phase 4 study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 300 participants.
The verdict
NCT03075163, a Phase 4 study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
This is a single site, prospective, randomized controlled study designed to evaluate the impact of acupressure when used as an initial treatment before rescue medications in the treatment of post-operative nausea and/or vomiting at UCD.
Interventions
- DRUG Ondansetron
- PROCEDURE Acupressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-10-18 |
| Est. Completion | 2018-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03075163
The ClinicalTrials.gov registry entry for NCT03075163 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ondansetron is the first listed.
NCT03075163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03075163 about?
NCT03075163 is a clinical study titled "Post-Operative Therapy for Nausea or Vomiting". This is a single site, prospective, randomized controlled study designed to evaluate the impact of acupressure when used as an initial treatment before rescue medications in the treatment of post-operative nausea and/or vomiting at UCD.
What is the current status of trial NCT03075163?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2016-10-18. Estimated completion is 2018-12.
What interventions are being tested in trial NCT03075163?
The interventions under investigation include: Ondansetron (DRUG), Acupressure (PROCEDURE).
Who is sponsoring clinical trial NCT03075163?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.